Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic

Status Not yet recruiting

Clinical Trial Summary

The overarching goal of this pilot study is to assess the feasibility and safety of transcutaneous auricular neurostimulation (tan) in ICU patients with TBi and to determine the effect of tan on serum markers of inflammation. exploratory analyses will examine effects on such physiological parameters as blood pressure, heart rate, and intracranial pressure (iCP), as well as measures of neurological function.

Clinical Trial Description

This is a single-center, open-label, nonrandomized investigation. TBI patients with a post resuscitation Glasgow Coma Scale (GCS) score of 12 or less (commonly described as moderate or severe TBI) and acute traumatic intradural blood on head CT scan will be screened upon admission to the ICU at Parkland Memorial Hospital. It is expected that all or almost all subjects will be in the Neuroscience or Surgical ICU. Consent for participation will be sought from the subject's legally authorized representative. Exception from informed consent or waiver of consent will not be part of this study. tAN will begin as soon as feasible after subject enrollment. Immediately prior to this intervention, vital signs, neurologic status, and other clinical parameters will be recorded, and pre-tAN blood will be collected for measurement of serum inflammatory markers. tAN will be administered for 30 minutes under the supervision of a member of the research team. After 30 minutes (just prior to stopping tAN), the same clinical parameters that were recorded at baseline will again be recorded then tAN will be stopped. Approximately two hours after tAN has ended, a post-tAN blood sample will be collected for measurement of the same inflammatory markers as in the pre-tAN blood sample. At each timepoint for blood collection, additional blood may be collected for banking and future analyses. Patients will undergo research blood draws and tAN stimulation for a maximum of 10 days. Research-related procedures will not exceed this 10-day period. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06467708
Study type	Interventional
Source	University of Texas Southwestern Medical Center
Contact	Alex Valadka, MD
Phone	2146452300
Email	alex.valadka@utsouthwestern.edu
Status	Not yet recruiting
Phase	N/A
Start date	July 2024
Completion date	June 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04526639` - VR Cognitive Rehabiliation for Pediatric TBI	N/A
Recruiting	`NCT05943756` - Evaluation of Well-being Interventions in Adults With TBI	N/A
Completed	`NCT01339702` - The EPIC Project: Impact of Implementing the EMS Traumatic Brain Injury Treatment Guidelines
Completed	`NCT00760734` - Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD)	Phase 1
Not yet recruiting	`NCT06024122` - Brain Development in Young Children Following Mild Traumatic Brain Injury - Pilot Study
Completed	`NCT03896789` - Pediatric Guideline Adherence and Outcomes- Argentina	N/A
Completed	`NCT03225768` - Guided Training for People With Cognitive Impairment	N/A
Completed	`NCT04590911` - Effectiveness of Multimodal Cognitive Rehabilitation for Traumatic Brain Injury Sustained During Older Adulthood	N/A
Recruiting	`NCT04121780` - Growth Hormone Replacement Therapy for Retried Professional Football Players	Phase 2
Completed	`NCT04776304` - Art Therapy qEEG Study for Service Members With a Traumatic Brain Injury and Posttraumatic Stress Symptoms	N/A
Completed	`NCT00409058` - Teen Online Problem Solving (TOPS) - An Online Intervention Following TBI	N/A
Completed	`NCT00205491` - Pharmacological Intervention in Depression After Traumatic Brain Injury	Phase 4
Completed	`NCT03490110` - Brain Markers of Improvements in Cognitive Functioning	N/A
Active, not recruiting	`NCT02525432` - Autologous Stem Cell Study for Adult TBI (Phase 2b)	Phase 2
Completed	`NCT02858544` - Concussion in Motor Vehicle Accidents: The Concussion Identification Index	N/A
Completed	`NCT01728831` - Study of Cerebral Tissue Oxygenation During Transfusion in Traumatic Brain Injury	N/A
Recruiting	`NCT06005194` - InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI	N/A
Not yet recruiting	`NCT05340803` - Sedation of Ventilated Traumatic Brain Injury Patients With Midazolam Alone Versus Combination With Dexmedetomidine or Magnesium Sulfate; Monitored by Ultrasonograghic Optic Nerve Sheath Diameter	Phase 3
Recruiting	`NCT06195345` - Individual Cerebral Hemodynamic Oxygenation Relationships (ICHOR 1)
Recruiting	`NCT04279431` - Follow-up of mTBI Patients Discharged From the ED Using Standard Clinical Triage Including BrainScope One

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury — tAN-TBI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms